The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III , randomised, double‐blind multicentre study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase
III
, randomised, double‐blind multicentre study
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 55, Issue 12, Pages 1524-1533
Publisher
Wiley
Online
2022-05-04
DOI
10.1111/apt.16959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastroscopic results for the asymptomatic, average-risk population in Northern China: a cross-sectional study of 60,519 adults
- (2022) Yan Gong et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Inverse correlation between gastroesophageal reflux disease and atrophic gastritis assessed by endoscopy and serology
- (2022) Yoo Min Han et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Chinese expert consensus on gastroesophageal reflux disease in 2020
- (2021) Ying Lian Xiao et al. Journal of Digestive Diseases
- Severe Hypomagnesemia Associated with the Long-term Use of the Potassium-competitive Acid Blocker Vonoprazan
- (2021) Masaru Okamoto et al. INTERNAL MEDICINE
- 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
- (2021) Hye-Kyung Jung et al. Journal of Neurogastroenterology and Motility
- Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world
- (2020) Daniel Sifrim et al. GUT
- Gastroesophageal Reflux Disease
- (2020) John Maret-Ouda et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Development of Foveolar-type Gastric Adenocarcinoma during Maintenance Therapy of Vonoprazan for Reflux Esophagitis
- (2020) Masahiro Saito et al. INTERNAL MEDICINE
- Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
- (2019) Kwang Jae Lee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Vonoprazan for 48-Week Maintenance Therapy of Patients with Healed Reflux Esophagitis
- (2019) Hideki Mizuno et al. DIGESTION
- Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
- (2019) Yinglian Xiao et al. GUT
- Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low‐grade esophagitis with low reflux burden
- (2019) Mengyu Zhang et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett’s Esophagus: An Analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium
- (2018) Zhensheng Wang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
- (2017) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis
- (2017) Leonardo H Eusebi et al. GUT
- Time trends in upper gastrointestinal diseases andHelicobacter pyloriinfection in a multiracial Asian population - a 20-year experience over three time periods
- (2016) A. H.-R. Leow et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression
- (2016) Carmelo Scarpignato et al. BMC Medicine
- Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus
- (2016) Kwong Ming Fock et al. GUT
- Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
- (2013) Hashem B El-Serag et al. GUT
- Risk Factors in the Development of Esophageal Adenocarcinoma
- (2012) Heiko Pohl et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Burden of Gastrointestinal Disease in the United States: 2012 Update
- (2012) Anne F. Peery et al. GASTROENTEROLOGY
- Prompt Upper Endoscopy Is an Appropriate Initial Management in Uninvestigated Chinese Patients With Typical Reflux Symptoms
- (2010) Sui Peng et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proton Pump Inhibitors
- (2009) Kwong Ming Fock et al. CLINICAL PHARMACOKINETICS
- Risk factors for the detection of Barrett's esophagus in patients with erosive esophagitis
- (2009) Nir Modiano et al. GASTROINTESTINAL ENDOSCOPY
- Epidemiology and clinical characteristics of GERD in the Japanese population
- (2009) Yasuhiro Fujiwara et al. JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now